The Scale of the Crisis
According to the World Health Organization, 1 in 4 people in the world will be affected by mental or neurological disorders at some point in their lives. Currently, around 450 million people suffer from such conditions.
Depression and anxiety alone cost the global economy more than $1 trillion each year in lost productivity. This figure continues to rise, highlighting the urgent need for effective interventions.
In low and middle-income countries, between 76% and 85% of people with severe mental disorders receive no treatment. Even in high-income countries, nearly 50% of people with depression do not get adequate care.
Key Challenges
Limited Treatment Options
Traditional approaches often rely on trial-and-error, with patients cycling through multiple medications before finding effective treatment.
Access Barriers
Geographic, economic, and social barriers prevent millions from accessing mental health services, even where they exist.
Lack of Precision
Without objective biomarkers, treatments are based on subjective assessments rather than precise, data-driven approaches.
Research Gaps
Understanding of brain mechanisms underlying mental health conditions remains incomplete, limiting development of new treatments.
